Browsing by Author "Calabuig-Fariñas, Sílvia"

Sort by: Order: Results:

  • Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2
    Galván-Femenía, Iván; Guindo Martínez, Marta; Duran Jordà, Xavier, 1974-; Calabuig-Fariñas, Sílvia; Mercader Bigas, Josep Maria; Ramirez, Jose Luis; Rosell, Rafael; Torrents, David; Carreras, Anna; Kohno, Takashi; Jantus-Lewintre, Eloisa; Camps, Carlos; Perucho, Manuel; Sumoy Van Dyck, Lauro; Yokota, Jun; Cid Ibeas, Rafael de (Elsevier, 2018)
    Objective: The aim of the study was to investigate the relationship between germline variations as a prognosis biomarker in patients with advanced Non-Small-Cell-Lung-Cancer (NSCLC) subjected to first-line platinum-based ...
  • NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
    Sánchez-Herrero, Estela; Serna-Blasco, Roberto; Ivanchuk, Vadym; García-Campelo, Rosario; Dómine Gómez, Manuel; Sánchez, José M.; Massutí, Bartomeu; Reguart, Noemí; Camps, Carlos; Sanz-Moreno, Sandra; Calabuig-Fariñas, Sílvia; Jantus-Lewintre, Eloisa; Arnal, Magdalena; Fernández-Orth, Dietmar; Calvo, Virginia; González-Rumayor, Víctor; Provencio, Mariano; Romero, Atocha (Wiley, 2021)
    Despite impressive and durable responses, nonsmall cell lung cancer (NSCLC) patients treated with anaplastic lymphoma kinase (ALK) inhibitors (ALK-Is) ultimately progress due to development of resistance. Here, we have ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking